Diabetes Mellitus — Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes
Citation(s)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) Compared With Placebo in Subjects With Type 2 Diabetes